PAVIA country specific meeting

The World Health Organization (WHO) has defined pharmacovigilance (PV) as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problems.”  The aim of PV systems is to protect the public from medicines-related harm. In 2018, the National Pharmacovigilance Center (NPC) conducted a Baseline assessment to identify strength and weaknesses of the Center (Eswatini). Based on the BLA, NPC prepared PV roadmap and a three years strategic plan aimed to Strengthen PV activities which will generate local, evidence-based information to improve patient care and safety through the identification, management, and prevention of medicine-related morbidity and mortality in patients. Present the situational analysis of the various aspects and needs of the PV systems in Eswatini at the start of the PAVIA project.

During the meeting the team came up with the work plan with six strategic objectives which are Coordination, Policy and Implementation Development System.  Adverse Events/Serious Adverse Events Recording and Reporting. Health Care Workers Capacity Development Clinical Management. Data Management and Analysis (Data Management Systems, Electronic System, and Causality Assessment) and Pharmacovigilance Awareness.